Should mirtazapine be discontinued before a colonoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mirtazapine Does Not Need to Be Held for Colonoscopy

Mirtazapine does not need to be discontinued before colonoscopy. There is no evidence-based requirement to hold this medication for routine colonoscopy procedures.

Rationale Based on Available Evidence

Colonoscopy Risk Classification

Colonoscopy with or without biopsy is classified as a low-risk procedure for bleeding 1. The major guidelines addressing medication management before endoscopy focus exclusively on:

  • Antiplatelet agents (aspirin, P2Y12 inhibitors)
  • Anticoagulants (warfarin, DOACs)
  • Medications that directly affect hemostasis

No gastroenterology or endoscopy guidelines recommend holding antidepressants, including mirtazapine, before colonoscopy 2, 3, 1, 3.

Mirtazapine-Specific Considerations

Bleeding Risk Profile

While SSRIs have documented associations with increased bleeding risk due to serotonin reuptake inhibition affecting platelet function, mirtazapine lacks serotonin reuptake inhibition. However, research shows mirtazapine may still carry a modest gastrointestinal bleeding risk (OR = 1.17,95% CI = 1.01-1.38) 4. This risk is:

  • Comparable to SSRIs in head-to-head comparisons
  • Not clinically significant enough to warrant routine discontinuation for low-risk procedures like diagnostic colonoscopy

Sedation Interactions

The FDA label warns that mirtazapine causes prominent sedation and can impair judgment and motor skills 5. When combined with procedural sedation medications (benzodiazepines, opioids), there is theoretical concern for:

  • Enhanced respiratory depression
  • Increased hypotension risk
  • Prolonged recovery time

However, these concerns do not constitute a contraindication to continuing mirtazapine. Standard monitoring during colonoscopy sedation is sufficient 6.

Bowel Preparation Considerations

The 2025 US Multi-Society Task Force guidelines on bowel preparation recommend temporary cessation of constipating medications (anticholinergics, opioids) in patients with prior inadequate bowel preparation 3. While mirtazapine can cause constipation as a side effect 5, it is not specifically listed among medications requiring discontinuation. If the patient has a history of inadequate bowel prep, consider:

  • Enhanced bowel preparation regimen (split-dose 4L PEG)
  • Low-residue diet 2-3 days before procedure
  • Patient navigation/education
  • Treatment of underlying constipation

Important Caveats

Do not abruptly discontinue mirtazapine even if considering holding it, as this can cause discontinuation syndrome 5. Any tapering must be gradual and discussed with the prescribing provider.

Continue mirtazapine through the procedure unless there are specific patient factors such as:

  • Severe sedation concerns in high-risk patients (ASA class III-V)
  • Recent overdose or toxicity
  • Active serotonin syndrome (though this would preclude elective colonoscopy entirely)

The medication can be taken with a small sip of water on the morning of the procedure, following standard NPO guidelines for clear liquids (typically up to 2 hours before procedure) 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.